Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00165438
Status:
COMPLETED
Last Update Posted:
2012-12-20
First Post:
2005-09-09
Brief Title:
Pulmonary Function in Patients With Hodgkins Disease Receiving Bleomycin-Based Chemotherapy
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Study Overview
Official Title:
A Prospective Study of Pulmonary Function in Patients With Hodgkins Disease Receiving Bleomycin-Based Chemotherapy With or Without Mediastinal Irradiation
Status:
COMPLETED
Status Verified Date:
2012-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out the impact Bleomycin-containing chemotherapy given with or without chest radiation therapy on patients lung function over time
Detailed Description:
The tests and procedures in this study are part of regular cancer care but this study offers more structured timing of these standard tests
Due to the potential lung toxicity associated with bleomycin-based chemotherapy pulmonary function tests are routinely performed Pulmonary function tests will be performed by a licensed registered respiratory therapist and performed prior to the beginning of treatment between the chemotherapy and radiation therapy only for patients receiving both chemotherapy and radiation therapy and at approximately 1 month 6 months 1 year and 2 years after the completion of all treatments
A CAT scan will be performed prior to the beginning of treatment and approximately 1 month 6 months 1 year and 2 years after the completion of all treatments
A self-administered questionnaire will be performed on the days the patient is undergoing pulmonary function tests
Due to the potential lung toxicity associated with bleomycin-based chemotherapy pulmonary function tests are routinely performed Pulmonary function tests will be performed by a licensed registered respiratory therapist and performed prior to the beginning of treatment between the chemotherapy and radiation therapy only for patients receiving both chemotherapy and radiation therapy and at approximately 1 month 6 months 1 year and 2 years after the completion of all treatments
A CAT scan will be performed prior to the beginning of treatment and approximately 1 month 6 months 1 year and 2 years after the completion of all treatments
A self-administered questionnaire will be performed on the days the patient is undergoing pulmonary function tests
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None